Meeting
2018 ASCO Annual Meeting
Incidence of Neuregulin1 (NRG1) gene fusions across tumor types.
Authors
Stephen V. Liu
Georgetown University Medical Center, Washington, DC
Stephen V. Liu , Rebecca Feldman , Hossein Borghaei , Shirish M. Gadgeel , Patrick C. Ma , Jorge J. Nieva , Alexander I. Spira , Ari M. Vanderwalde , Antoinette J. Wozniak , Sushma Jonna , Edward S. Kim
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Tumor Biology
Track
Tumor Biology
Sub Track
New Targets and New Technologies
Citation
J Clin Oncol 36, 2018 (suppl; abstr 12084)
DOI
10.1200/JCO.2018.36.15_suppl.12084
Abstract #
12084
Poster Bd #
197
Abstract Disclosures
Similar Posters
Poster
2019 ASCO Annual Meeting
Clinicopathologic characteristics of NRG1 fusion-positive cancers: A single-institution study.
First Author: Alison M. Schram
Poster
2023 ASCO Annual Meeting
Effects of mutations in SWI/SNF subunits on context-specific prognosis in driver positive and driver negative NSCLC.
First Author: Benjamin Herzberg
Poster
2021 ASCO Annual Meeting
Impact of rapid multigene assays with short turnaround time (TAT) on the development of precision medicine for non-small cell lung cancer (NSCLC).
First Author: Shingo Matsumoto
Poster
2020 ASCO Virtual Scientific Program
Establishment of the first international large-scale, genomic screening platform to identify patients with rare oncogene drivers in non-small cell lung cancer (NSCLC) in East Asia.
First Author: Shingo Matsumoto